Journal article
Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers
CG Begley, M Ashton, J Baell, M Bettess, MP Brown, B Carter, WN Charman, C Davis, S Fisher, I Frazer, A Gautam, MP Jennings, P Kearney, E Keeffe, D Kelly, AF Lopez, M McGuckin, MW Parker, C Rayner, B Roberts Show all
Science Translational Medicine | AMER ASSOC ADVANCEMENT SCIENCE | Published : 2021
Abstract
Drug repurposing is promoted as a cost- and time-effective mechanism for providing new medicines. Often, however, there is insufficient consideration by academic researchers of the processes required to ensure that a repurposed drug can be used for a new indication. This may explain the inability of drug repurposing to fulfill its promise. Important aspects, often overlooked, include financial and intellectual property considerations, the clinical and regulatory path, and clinical equipoise, which provides ethical justification for randomized controlled trials. The goal of drug repurposing is to obtain a new regulator-approved label for an existing drug, and so, the trajectory for drug repur..
View full abstractGrants
Funding Acknowledgements
J.B., M.P.B., M. P.J., I.F., D.K., M.M., M.W.P., and A.F. L. are supported by research grants from the Australian National Health and Medical Research Council. M. W.P. is supported by research grants from the Australian Research Council.